Metformin's contraindications should be contraindicated

McCormack, James; Johns, Kevin; Tildesley, Hugh
August 2005
CMAJ: Canadian Medical Association Journal;8/30/2005, Vol. 173 Issue 5, p502
Academic Journal
Offers views on whether contraindications to metformin therapy are warranted for certain patients with type 2 diabetes. Contraindications to the use of metformin listed in the "Compendium of Pharmaceuticals and Specialties"; Benefits of metformin use; Risk of lactic acidosis among patients who use metformin.


Related Articles

  • Metformin.  // Reactions Weekly;9/27/2008, Issue 1221, p23 

    The article describes the case of a 64-year-old woman who developed lactic acidosis while being treated with metformin for type 2 diabetes mellitus. The woman, who had a history of hypertension and mild chronic renal failure, underwent gynaecological surgery and developed oliguria, confusion,...

  • Initial sitagliptin plus metformin demonstrated to be effective in patients with type 2 diabetes.  // Formulary;Sep2007, Vol. 42 Issue 9, p562 

    The article reports on the result of a study which suggests that initial treatment of sitagliptin and metformin showed to be effective in patients with type 2 diabetes in the U.S. It is asserted that treatment of type 2 diabetes with initial monotherapy is often unsuccessful in terms of reaching...

  • Metformin: A New Treatment Option for Non-Insulin-Dependent Diabetes Mellitus. Goo, Alvin K. Y.; Carson, Deborah Stier; Bjelajac, Aleksandra // Journal of Family Practice;Jun1996, Vol. 42 Issue 6, p612 

    Metformin is a biguanide that can used alone or in combination with sulfonylureas or insulin in the treatment of non-insulin-dependent diabetes mellitus (NIDDM). Since biguanides do not increase pancreatic insulin secretion, they are referred to as antihyperglycemic agents, as opposed to...

  • Metformin.  // Reactions Weekly;7/26/2008, Issue 1212, p20 

    The article describes case study involving a 75-year-old woman who developed lactic acidosis during treatment with metformin for type 2 diabetes mellitus (T2DM). She presenetd with severe weakness, malaise and dehydration due to diarrhea. Among the medication she had received was metformin for...

  • Metformin.  // Reactions Weekly;7/26/2008, Issue 1212, p20 

    The article describes case studies involving ten women and three men, aged 65-77 years, who developed lactic acidosis during treatment with metformin for type 2 diabetes mellitus. The patients were hospitalized and diagnosed with lactic acidosis and the trigger factor was acute GI process with...

  • Licensing drugs for diabetes. Lehman, Richard; Yudkin, John S.; Krumholz, Harlan M. // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;9/11/2010, Vol. 341 Issue 7772, p513 

    The authors call on regulatory agencies to require manufacturers of new drugs to provide definite evidence of greater benefits of their products than harm to patients. They cite the controversy over the safety of the diabetes drug rosiglitazone (Avandia) as an example of the failure of...

  • Insulin Management of Type 2 Diabetes Mellitus. PETZNICK, ALLISON // American Family Physician;7/15/2011, Vol. 84 Issue 2, p183 

    Insulin therapy is recommended for patients with type 2 diabetes mellitus and an initial A1C level greater than 9 percent, or if diabetes is uncontrolled despite optimal oral glycemic therapy. Insulin therapy may be initiated as augmentation, starting at 0.3 unit per kg, or as replacement,...

  • Application of Berberine on Treating Type 2 Diabetes Mellitus. Pang, Bing; Zhao, Lin-Hua; Zhou, Qiang; Zhao, Tian-Yu; Wang, Han; Gu, Cheng-Juan; Tong, Xiao-Lin // International Journal of Endocrinology;3/11/2015, Vol. 2015, p1 

    Traditional Chinese medicine (TCM) performs a good clinical practice and is showing a bright future in the treatment of diabetes mellitus (DM). TCM treatment has certain advantages of less toxicity and/or side effects, and herbs could provide multiple therapeutic effects. Berberine (BBR) is a...

  • Treating dual defects in diabetes:Insulin resistance and insulin secretion. Bohannon, Nancy J.V. // American Journal of Health-System Pharmacy;12/2/2002 Supplement, Vol. 59, pS9 

    The therapeutic goals in patients with type 2 diabetes mellitus and the mechanisms of insulin resistance and se- cretion are discussed. Sulfonylureas improve glycemic control, restore the acute insulin response,and help improve beta-cell function in the short term.Meglitinides and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics